Endovascular Magnesium Sampling in Acute Stroke

Stopped early · Not applicable

Conditions studied: Acute Stroke

In brief

This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute stroke. This study attempts to address whether the traditional intravenous means of neuroprotectant administration achieves adequate concentration of the therapeutic agent in the area of diseased tissue.

Key facts

Study ID

NCT01502748

Run by

University of Southern California

People needed

2

Starts

2012-03-01

Expected to finish

2013-02-01

Last updated by the study team

2017-08-01

Who can join

Age: 40 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with acute cerebral ischemia due to ICA or MCA occlusion,
• Patient already enrolled in the NIH FAST-MAG clinical trial,
• Patient's clinical attending physician plans mechanical embolectomy procedure as part of routine clinical care.
• Age 40-95 inclusive (age criteria for FAST-MAG Trial).

You may not qualify if…

• Technical inability to navigate microcatheter to target clot.
• Patient or surrogate unavailable for consent

Where it is running

• University California Los Angeles: Ronald Reagan and Santa Monica Hospitals — Los Angeles, California, United States
• University of Southern California University and LA County Hospitals — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.